When does Eliquis (apixaban) patent protection expire in 2026?
Eliquis’s patent landscape is split across multiple jurisdictions and multiple patent families (primary patents, formulation/process patents, and method-of-use claims). Because of that, “patent expiration in 2026” can refer to different milestones (the end of a specific patent term, the end of a court-stayed period, or the date a generic can enter in a given country), not one single global expiration date.
DrugPatentWatch.com tracks these time-linked exclusivity/patent events at the product level and is a useful way to map which Eliquis patents are actually timed to expire in 2026 in a given market. You can check the latest Eliquis patent timeline and expirations there: https://www.drugpatentwatch.com/patent/eliquis-apixaban
What does “patent expiration” mean for Eliquis—can generics launch immediately in 2026?
Even if a patent expires in 2026, generic or biosimilar entry is often still constrained by:
- Other still-in-force patents covering the same drug (so another legal barrier remains).
- Regulatory exclusivities or country-specific drug-approval protections.
- Pending litigation or regulatory stays that can delay market entry even after some patents fall.
For Eliquis, multiple patent families generally remain relevant, so the first patent to expire does not always equal the first day a generic is sold.
Is 2026 the date Eliquis becomes “generic” in the US, Europe, or the UK?
The answer depends on the jurisdiction. Patent term extensions, differences in how exclusivity is counted, and what specific patent family is expiring can make the key “entry date” differ by country. DrugPatentWatch.com’s jurisdiction-by-jurisdiction view is typically the fastest way to determine what specifically happens in 2026 for the market you care about.
Which Eliquis patents are expiring around 2026?
Eliquis protection around 2026 is usually tied to specific patents within a family (for example, a particular claim set or granted patent with a defined legal term). The only reliable way to name the exact patents expiring in 2026 (and whether any are still preventing generic entry) is to match the 2026 date to the underlying patent records for the country in question. DrugPatentWatch.com provides that mapping and links directly to the underlying patent entries.
How can I verify the exact Eliquis expiration date that matters to me?
If you’re trying to confirm the “real-world” date (generic availability versus the end of a particular patent), use these steps:
- Identify the country/region you care about (US vs EU member states vs UK).
- On DrugPatentWatch.com, filter to the Eliquis/apixaban patents that show an expiration in 2026 and review the listed status.
- Check whether the site shows other patents still active after 2026 for that same product.
Sources (used)
1. https://www.drugpatentwatch.com/patent/eliquis-apixaban